This article is more than 5 years old. Information may no longer be current.
ASH elects three to executive committee
Click Here to Manage Email Alerts
ASH announced the election of three new members to its executive committee, the governing body of the organization.
Alexis A. Thompson, MD, MPH, will serve a 1-year term as vice president, followed by successive terms as president-elect and president. Steven L. Allen, MD, and Jane N. Winter, MD, each will serve 4-year terms as councillors.
Alexis A. Thompson
Their terms will take effect after the ASH Annual Meeting and Exposition, scheduled for Dec. 5-8 in Orlando.
“Hematology is experiencing a period of unprecedented growth as a result of previous investments in research and new technologies, as well as evolving insights in the way we treat blood disorders,” David A. Williams, MD, ASH president for 2015, president of Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and professor of pediatrics at Harvard Medical School, said in a press release. “These advances necessitate continued commitments to funding, training, and access to care that will require thoughtful leadership. I am delighted to welcome Drs. Thompson, Allen, and Winter and am excited about the diverse perspectives they represent.”
Thompson is head of the hematology section of the division of hematology, oncology and transplantation and director of the comprehensive thalassemia program at Ann and Robert H. Lurie Children’s Hospital of Chicago, where she also serves as A. Watson and Sarah Armour endowed chair for childhood cancer and blood disorders. Thompson also is associate director of equity and minority health at Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
Her major fields of interest include sickle cell disease, thalassemia, transfusional iron overload and stem cell transplantation for pediatric patients.
Winter is professor of medicine in the division of hematology/oncology at Feinberg School of Medicine of Northwestern University in Chicago. She also serves as a member of Robert H. Lurie Comprehensive Cancer Center. Her research interests include the clinical and biologic markers of prognosis in diffuse large B-cell lymphoma and clinical trials with novel agents in lymphoma.
Allen is associate chief of hematology at Monter Cancer Center, North Shore-LIJ Health System and professor of medicine at Hofstra North Shore-LIJ School of Medicine. Allen has maintained an active clinical practice and has been highly involved in the society’s practice initiatives for more than 30 years. He serves as chair of the committee on practice and is a participant in the ASH Practice Partnership program.